secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001099800-24-000054
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences principal accounting officer Sellers retires; Dahl named successor effective July 1
--------------------------------------------------------------------------------

- Robert W.A. Sellers, Senior VP and Principal Accounting Officer, retires effective July 1, 2024.
- Andrew M. Dahl, currently Senior VP and Corporate Controller, succeeds Sellers as Principal Accounting Officer.
- Dahl joined Edwards in February 2024; prior roles include VP at Medtronic and Manager at Deloitte.
- No material interest, arrangement, or family relationship exists between Dahl and Edwards officers or directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/0001099800-24-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/ew-20240614.htm
  HTML page:      https://secwatch.observer/filing/0001099800-24-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer